Cancer Oncology Testing - Global and China Top Players Market Share and Ranking 2023

Tables and Figures

Table 1. Cancer Oncology Testing Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Cancer Oncology Testing Market Restraints
Table 3. Cancer Oncology Testing Market Trends
Table 4. Cancer Oncology Testing Industry Policy
Table 5. Global Cancer Oncology Testing Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Cancer Oncology Testing Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Cancer Oncology Testing Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 8. Global Cancer Oncology Testing Mergers & Acquisitions, Expansion Plans
Table 9. Global Cancer Oncology Testing Major Companies Product Type
Table 10. Head Office and Area Served of Key Players
Table 11. China Cancer Oncology Testing Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 12. China Cancer Oncology Testing Revenue Market Share by Company, 2018-2023
Table 13. Global Key Players of Cancer Oncology Testing Upstream (Raw Materials)
Table 14. Global Cancer Oncology Testing Typical Customers
Table 15. Cancer Oncology Testing Typical Distributors
Table 16. By Type, Global Cancer Oncology Testing Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 17. By Application, Global Cancer Oncology Testing Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 18. By Region, Global Cancer Oncology Testing Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 19. By Region, Global Cancer Oncology Testing Consumption Value, 2018-2029, US$ Million
Table 20. By Country, Global Cancer Oncology Testing Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 21. By Country, Global Cancer Oncology Testing Consumption Value, 2018-2029, US$ Million
Table 22. By Country, Global Cancer Oncology Testing Consumption Value Market Share, 2018-2029
Table 23. Devyser Company Information, Head Office, Market Area and Industry Position
Table 24. Devyser Company Profile and Main Business
Table 25. Devyser Cancer Oncology Testing Models, Specifications, and Application
Table 26. Devyser Cancer Oncology Testing Revenue and Gross Margin, US$ Million, 2018-2023
Table 27. Devyser Recent Developments
Table 28. Agendia Company Information, Head Office, Market Area and Industry Position
Table 29. Agendia Company Profile and Main Business
Table 30. Agendia Cancer Oncology Testing Models, Specifications, and Application
Table 31. Agendia Cancer Oncology Testing Revenue and Gross Margin, US$ Million, 2018-2023
Table 32. Agendia Recent Developments
Table 33. Illumina Company Information, Head Office, Market Area and Industry Position
Table 34. Illumina Company Profile and Main Business
Table 35. Illumina Cancer Oncology Testing Models, Specifications, and Application
Table 36. Illumina Cancer Oncology Testing Revenue and Gross Margin, US$ Million, 2018-2023
Table 37. Illumina Recent Developments
Table 38. Personal Genome Diagnostics Company Information, Head Office, Market Area and Industry Position
Table 39. Personal Genome Diagnostics Company Profile and Main Business
Table 40. Personal Genome Diagnostics Cancer Oncology Testing Models, Specifications, and Application
Table 41. Personal Genome Diagnostics Cancer Oncology Testing Revenue and Gross Margin, US$ Million, 2018-2023
Table 42. Personal Genome Diagnostics Recent Developments
Table 43. Veracyte Company Information, Head Office, Market Area and Industry Position
Table 44. Veracyte Company Profile and Main Business
Table 45. Veracyte Cancer Oncology Testing Models, Specifications, and Application
Table 46. Veracyte Cancer Oncology Testing Revenue and Gross Margin, US$ Million, 2018-2023
Table 47. Veracyte Recent Developments
Table 48. Pacific Biosciences of California Company Information, Head Office, Market Area and Industry Position
Table 49. Pacific Biosciences of California Company Profile and Main Business
Table 50. Pacific Biosciences of California Cancer Oncology Testing Models, Specifications, and Application
Table 51. Pacific Biosciences of California Cancer Oncology Testing Revenue and Gross Margin, US$ Million, 2018-2023
Table 52. Pacific Biosciences of California Recent Developments
Table 53. Qiagen Company Information, Head Office, Market Area and Industry Position
Table 54. Qiagen Company Profile and Main Business
Table 55. Qiagen Cancer Oncology Testing Models, Specifications, and Application
Table 56. Qiagen Cancer Oncology Testing Revenue and Gross Margin, US$ Million, 2018-2023
Table 57. Qiagen Recent Developments
Table 58. Agilent Technologies Company Information, Head Office, Market Area and Industry Position
Table 59. Agilent Technologies Company Profile and Main Business
Table 60. Agilent Technologies Cancer Oncology Testing Models, Specifications, and Application
Table 61. Agilent Technologies Cancer Oncology Testing Revenue and Gross Margin, US$ Million, 2018-2023
Table 62. Agilent Technologies Recent Developments
Table 63. Natera Company Information, Head Office, Market Area and Industry Position
Table 64. Natera Company Profile and Main Business
Table 65. Natera Cancer Oncology Testing Models, Specifications, and Application
Table 66. Natera Cancer Oncology Testing Revenue and Gross Margin, US$ Million, 2018-2023
Table 67. Natera Recent Developments
Table 68. Bio Rad Laboratories Company Information, Head Office, Market Area and Industry Position
Table 69. Bio Rad Laboratories Company Profile and Main Business
Table 70. Bio Rad Laboratories Cancer Oncology Testing Models, Specifications, and Application
Table 71. Bio Rad Laboratories Cancer Oncology Testing Revenue and Gross Margin, US$ Million, 2018-2023
Table 72. Bio Rad Laboratories Recent Developments
Table 73. Myriad Genetics Company Information, Head Office, Market Area and Industry Position
Table 74. Myriad Genetics Company Profile and Main Business
Table 75. Myriad Genetics Cancer Oncology Testing Models, Specifications, and Application
Table 76. Myriad Genetics Cancer Oncology Testing Revenue and Gross Margin, US$ Million, 2018-2023
Table 77. Myriad Genetics Recent Developments
List of Figures
Figure 1. Cancer Oncology Testing Picture
Figure 2. Global Cancer Oncology Testing Consumption Value, (US$ million) & (2018-2029)
Figure 3. China Cancer Oncology Testing Consumption Value, (US$ million) & (2018-2029)
Figure 4. By Consumption Value, China Cancer Oncology Testing Market Share of Global, 2018-2029
Figure 5. Global Cancer Oncology Testing Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 6. China Cancer Oncology Testing Key Participants, Market Share, 2022
Figure 7. Cancer Oncology Testing Industry Chain
Figure 8. Cancer Oncology Testing Procurement Model
Figure 9. Cancer Oncology Testing Sales Model
Figure 10. Cancer Oncology Testing Sales Channels, Direct Sales, and Distribution
Figure 11. Fluorescence In Situ Hybridization
Figure 12. Polymerase Chain Reaction
Figure 13. Microarray Technology
Figure 14. Serum Proteomics
Figure 15. Nucleic Acid Sequencing
Figure 16. By Type, Global Cancer Oncology Testing Consumption Value, 2018-2029, US$ Million
Figure 17. By Type, Global Cancer Oncology Testing Consumption Value Market Share, 2018-2029
Figure 18. Hospitals
Figure 19. Speciality Clinics
Figure 20. Research Institutes
Figure 21. Diagnostics Laboratories
Figure 22. Biopharmaceutical Companies
Figure 23. By Application, Global Cancer Oncology Testing Consumption Value, 2018-2029, US$ Million
Figure 24. By Application, Global Cancer Oncology Testing Consumption Value Market Share, 2018-2029
Figure 25. By Region, Global Cancer Oncology Testing Consumption Value Market Share, 2018-2029
Figure 26. North America Cancer Oncology Testing Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 27. By Country, North America Cancer Oncology Testing Consumption Value Market Share, 2022
Figure 28. Europe Cancer Oncology Testing Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 29. By Country, Europe Cancer Oncology Testing Consumption Value Market Share, 2022
Figure 30. Asia Pacific Cancer Oncology Testing Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 31. By Country/Region, Asia Pacific Cancer Oncology Testing Consumption Value Market Share, 2022
Figure 32. South America Cancer Oncology Testing Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 33. By Country, South America Cancer Oncology Testing Consumption Value Market Share, 2022
Figure 34. Middle East & Africa Cancer Oncology Testing Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 35. U.S. Cancer Oncology Testing Consumption Value, 2018-2029, US$ Million
Figure 36. By Type, U.S. Cancer Oncology Testing Consumption Value Market Share, 2022 VS 2029
Figure 37. By Application, U.S. Cancer Oncology Testing Consumption Value Market Share, 2022 VS 2029
Figure 38. Europe Cancer Oncology Testing Consumption Value, 2018-2029, US$ Million
Figure 39. By Type, Europe Cancer Oncology Testing Consumption Value Market Share, 2022 VS 2029
Figure 40. By Application, Europe Cancer Oncology Testing Consumption Value Market Share, 2022 VS 2029
Figure 41. China Cancer Oncology Testing Consumption Value, 2018-2029, US$ Million
Figure 42. By Type, China Cancer Oncology Testing Consumption Value Market Share, 2022 VS 2029
Figure 43. By Application, China Cancer Oncology Testing Consumption Value Market Share, 2022 VS 2029
Figure 44. Japan Cancer Oncology Testing Consumption Value, 2018-2029, US$ Million
Figure 45. By Type, Japan Cancer Oncology Testing Consumption Value Market Share, 2022 VS 2029
Figure 46. By Application, Japan Cancer Oncology Testing Consumption Value Market Share, 2022 VS 2029
Figure 47. South Korea Cancer Oncology Testing Consumption Value, 2018-2029, US$ Million
Figure 48. By Type, South Korea Cancer Oncology Testing Consumption Value Market Share, 2022 VS 2029
Figure 49. By Application, South Korea Cancer Oncology Testing Consumption Value Market Share, 2022 VS 2029
Figure 50. Southeast Asia Cancer Oncology Testing Consumption Value, 2018-2029, US$ Million
Figure 51. By Type, Southeast Asia Cancer Oncology Testing Consumption Value Market Share, 2022 VS 2029
Figure 52. By Application, Southeast Asia Cancer Oncology Testing Consumption Value Market Share, 2022 VS 2029
Figure 53. India Cancer Oncology Testing Consumption Value, 2018-2029, US$ Million
Figure 54. By Type, India Cancer Oncology Testing Consumption Value Market Share, 2022 VS 2029
Figure 55. By Application, India Cancer Oncology Testing Consumption Value Market Share, 2022 VS 2029
Figure 56. Middle East & Africa Cancer Oncology Testing Consumption Value, 2018-2029, US$ Million
Figure 57. By Type, Middle East & Africa Cancer Oncology Testing Consumption Value Market Share, 2022 VS 2029
Figure 58. By Application, Middle East & Africa Cancer Oncology Testing Consumption Value Market Share, 2022 VS 2029
Figure 59. Research Methodology
Figure 60. Breakdown of Primary Interviews
Figure 61. Bottom-up and Top-down Approaches
Figure 62. Top-down Approaches

Reason to Buy

• Current and future of Uncategorized Market outlook in the developed and emerging markets
• Highlights key business priorities in order to assist companies to realign their business strategies
• The segment that is expected to dominate the Uncategorized Market
• Regions that are expected to witness the fastest growth during the forecast period
• Identify the latest developments, Uncategorized Market shares, and strategies employed by the major market players
• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Uncategorized Market
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets